Status:

RECRUITING

PROtein, Leucine and Vitamin D Supplementation In Patients With GYnecologic Cancer Receiving Platinum-based Chemotherapy

Lead Sponsor:

Fondazione IRCCS Policlinico San Matteo di Pavia

Conditions:

Gynecologic Cancer

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Open clinical trial addressing the effect of a nutritional support based on whey proteins, leucine and vitamin D on muscle mass and multiple anticancer treatment-related endpoints in patients with gyn...

Eligibility Criteria

Inclusion

  • histologically confirmed diagnosis of gynecologic cancer (ovarian, uterine, cervical);
  • indication for a first-line chemotherapy (adjuvant or curative) with a platinum-based regimen to be used by investigator's choice within the framework of good clinical practice and in agreement with current Italian Association of Medical Oncology guidelines;
  • Eastern Cooperative Oncology Group (ECOG) performance status ≤2;
  • signed informed consent.

Exclusion

  • age \<18 years
  • ECOG performance status \>2
  • indication to or ongoing artificial nutrition support
  • known kidney failure (previous glomerular filtration rate \<30 ml/min);
  • known liver failure (Child B or C)
  • endocrine disorders associated with disorders of calcium metabolism (excluding osteoporosis)
  • decompensated diabetes
  • indications related to the study product: more than 10 µg (400 IU) of daily Vitamin D intake from medical sources More than 500 mg of daily calcium intake from medical sources; adherence to a high energy or high protein diet up or use of protein containing or amino acid containing nutritional supplements up to three months before starting the study.
  • known allergy to milk, milk products or other components of the proposed interventions
  • inclusion in other nutritional intervention trials
  • patients refusal

Key Trial Info

Start Date :

July 8 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 30 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06087783

Start Date

July 8 2024

End Date

November 30 2026

Last Update

May 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IRCCS San Matteo

Pavia, Italy, Italy, 27100